RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FWBI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for First Wave BioPharma, Inc. stock after losing 1.49%
(Updated on Apr 30, 2024)

Sell candidate since Mar 14, 2024 Loss -50.84% PDF

The First Wave BioPharma, Inc. stock price fell by -1.49% on the last day (Tuesday, 30th Apr 2024) from $2.68 to $2.64. During the last trading day the stock fluctuated 4.20% from a day low at $2.62 to a day high of $2.73. The price has fallen in 7 of the last 10 days and is down by -12.58% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -27 thousand shares and in total, 8 thousand shares were bought and sold for approximately $22.29 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.20 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -34.25% during the next 3 months and, with a 90% probability hold a price between $1.44 and $4.52 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

FWBI Signals & Forecast

There are mixed signals in the stock today. The First Wave BioPharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.83 and $3.84. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 1.54%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for First Wave BioPharma, Inc. stock

First Wave BioPharma, Inc. finds support from accumulated volume at $2.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.110 between high and low, or 4.20%. For the last week the stock has had daily average volatility of 9.36%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FWBI) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect First Wave BioPharma, Inc. to open at $2.66, and during the day (based on 14 day Average True Range), to move between $2.25 and $3.03, which gives a possible trading interval of +/-$0.389 (+/-14.75%) up or down from last closing price. If First Wave BioPharma, Inc. takes out the full calculated possible swing range there will be an estimated 29.50% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.60 (1.52%) than the resistance at $2.91 (10.23%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is First Wave BioPharma, Inc. stock A Buy?

First Wave BioPharma, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.716 Sell Candidate Unchanged

Predicted Opening Price for First Wave BioPharma, Inc. of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
$2.66 ( 0.88%) $2.64

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FWBI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.77 5.05 %
R2 2.73 3.46 %
R1 2.71 2.48 %
Current price: 2.64
Support S1 2.62 -0.708 %
S2 2.60 -1.69 %
S3 2.55 -3.28 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.12 18.18 %
R2 3.02 14.39 %
R1 2.91 10.23 %
Current price 2.64
Support S1 2.60 -1.52%
S2 0 .
S3 0 .

FAQ

What is the symbol for First Wave BioPharma, Inc. Stock and on which exchange is it traded?
The symbol for First Wave BioPharma, Inc. is FWBI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell First Wave BioPharma, Inc. Stock?
First Wave BioPharma, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy First Wave BioPharma, Inc. Stock?
First Wave BioPharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy First Wave BioPharma, Inc. Stock.

What's the current price of First Wave BioPharma, Inc. Stock?
As of the end of day on the Apr 30, 2024, the price of an First Wave BioPharma, Inc. (FWBI) share was $2.64.

What is the 52-week high and low for First Wave BioPharma, Inc. Stock?
The 52-week high for First Wave BioPharma, Inc. Stock is $14.50 and the 52-week low is $0.221.

What is the market capitalization of First Wave BioPharma, Inc. Stock?
As of the Apr 30, 2024, the market capitalization of First Wave BioPharma, Inc. is 5.428M.

When is the next earnings date for First Wave BioPharma, Inc.?
The upcoming earnings date for First Wave BioPharma, Inc. is May 10, 2024.
Click to get the best stock tips daily for free!

About First Wave BioPharma, Inc.

First Wave BioPharma. First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties; and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. T... FWBI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT